Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Manal M Alem"'
Publikováno v:
Clinical Medicine Insights: Cardiology, Vol 12 (2018)
Background: The xanthine oxidase inhibitor allopurinol improves endothelial function in different populations, including patients with chronic heart failure (CHF). Its effect on arterial stiffness parameters is less clear. We investigated the effect
Externí odkaz:
https://doaj.org/article/ba1dc284057448829678685555c75209
Autor:
Alanood A. Howsawi, Manal M. Alem
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract Glycemic variability (GV), independently of glycemic control, has emerged as a prognostic marker in patients with type 2 diabetes mellitus (DM). In this study, we assessed the prognostic value of long-term GV for predicting major adverse car
Externí odkaz:
https://doaj.org/article/80c02a40306a4b9abbe1bc5962cc004a
Autor:
Manal M. Alem
Publikováno v:
Heliyon, Vol 8, Iss 11, Pp e11549- (2022)
Background: Type 2 diabetes mellitus (DM), gout, and asymptomatic hyperuricemia are inter-connected pathologies. Glycemic control (GC), involving a range of treatments is central to the management of DM, whereas allopurinol continues to be the most w
Externí odkaz:
https://doaj.org/article/322bb704cc6041dfa0d25ef55ea4c5a1
Autor:
Doaa R. Adam, Manal M. Alem
Publikováno v:
Biomedicines, Vol 11, Iss 1, p 46 (2022)
Erectile dysfunction (ED) is a public health concern worldwide. In the past, it was perceived as a phenomenon attributed to age advancement. However, more individuals are affected every year that do not fall under that age criterion. Epidemiological
Externí odkaz:
https://doaj.org/article/c8d2f74b0fa34d2c8ae25de1803743a3
Autor:
Manal M. Alem, Abdullah M. Alshehri
Publikováno v:
Journal of International Medical Research, Vol 48 (2020)
Objective To investigate the inter-relationships between left ventricular mass (LVM), left ventricular (LV) geometry and arterial stiffness parameters (aortic pulse wave velocity [Ao-PWV] and heart rate-corrected augmentation index [c-AIx]) in patien
Externí odkaz:
https://doaj.org/article/47e7818ef693492d9adecbcc1b0ccc32
Autor:
Manal M Alem
Publikováno v:
International Journal of General Medicine. 13:407-417
Background Chronic heart failure (CHF) is a global health burden. Despite advances in treatment, there remain well-recognised morbidity and mortality. Risk stratification requires the identification and validation of biomarkers, old and new. Hyponatr
Autor:
Adam S Obad, Manal M Alem, Bandar Al-Ghamdi, Nagy M Fagir, Sarah R Aldosari, Alhassna A Alkahmous
Publikováno v:
Vascular Health and Risk Management. 15:539-550
Background Left ventricular hypertrophy (LVH), as assessed by measurement of left ventricular mass (LVM), is one of the most important cardiovascular risk factors. It is commonly present in patients with ischemic heart disease (IHD), irrespective of
Autor:
Manal M. Alem
BackgroundType 2 diabetes mellitus (DM), gout, and asymptomatic hyperuricemia are inter-connected pathologies. Glycemic control (GC), involving a range of treatments is central to the management of DM, whereas allopurinol continues to be the most wid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::21ec705d9441739d1becf50cb7c76508
https://doi.org/10.21203/rs.3.rs-491373/v1
https://doi.org/10.21203/rs.3.rs-491373/v1
Autor:
Manal M Alem
Publikováno v:
International Journal of General Medicine
Manal M Alem Department of Pharmacology, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam, Saudi ArabiaCorrespondence: Manal M AlemDepartment of Pharmacology, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal Unive
Autor:
Manal M. Alem, Abdullah M. Alshehri, Muruj A. Alshehri, Mohammed H. AlElaiw, Ali A. Almaa, Rami T. Bustami
Publikováno v:
Electronic Journal of General Medicine. 19:em338